Trial Profile
An Open label, Randomized, Controlled study to assess the efficacy of Olmesartan and Chlortalidone on Arterial Stiffness In Patients With Newly Diagnosed Essential Hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2015
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Chlortalidone
- Indications Essential hypertension
- Focus Therapeutic Use
- 04 Aug 2015 New trial record
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.